Log in to save to my catalogue

UBE2O promotes lipid metabolic reprogramming and liver cancer progression by mediating HADHA ubiquit...

UBE2O promotes lipid metabolic reprogramming and liver cancer progression by mediating HADHA ubiquit...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2727638446

UBE2O promotes lipid metabolic reprogramming and liver cancer progression by mediating HADHA ubiquitination

About this item

Full title

UBE2O promotes lipid metabolic reprogramming and liver cancer progression by mediating HADHA ubiquitination

Publisher

London: Nature Publishing Group UK

Journal title

Oncogene, 2022-11, Vol.41 (48), p.5199-5213

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Cancer cells rely on heightened protein quality control mechanisms, including the ubiquitin-proteosome system that is predominantly driven by ubiquitination comprising E1, E2, and E3 trienzyme cascades. Although E3s have been extensively studied, the implication of E2s in tumorigenesis is poorly defined. Here we reveal a critical E2 in the pathogen...

Alternative Titles

Full title

UBE2O promotes lipid metabolic reprogramming and liver cancer progression by mediating HADHA ubiquitination

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2727638446

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2727638446

Other Identifiers

ISSN

0950-9232

E-ISSN

1476-5594

DOI

10.1038/s41388-022-02509-1

How to access this item